Health Care & Life Sciences » Pharmaceuticals | HPGC Renmintongtai Pharmaceutical Corp.

HPGC Renmintongtai Pharmaceutical Corp. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,782.70
26,228.30
132,542.80
224,509.90
254,196.20
257,854.80
Depreciation, Depletion & Amortization
94,137.90
91,293.70
51,340.90
35,366.10
34,056.30
31,262.60
Other Funds
-
14,954.90
13,914.30
-
-
4,563.90
Funds from Operations
158,898.90
195,273.80
261,528.40
271,906.30
291,089.20
289,266.70
Changes in Working Capital
317,211.10
197,305.00
72,459.20
231,059.80
159,200.40
77,185.10
Net Operating Cash Flow
158,312.30
392,578.80
333,987.60
40,846.50
131,888.90
366,451.80
Capital Expenditures
33,000.00
17,063.50
35,580.00
22,813.00
7,098.30
Sale of Fixed Assets & Businesses
6,914.30
11,212.40
196.20
881.20
100.50
Purchase/Sale of Investments
8,820.00
-
-
-
-
Net Investing Cash Flow
121,729.10
28,275.90
135,761.20
21,931.80
6,997.80
Cash Dividends Paid - Total
16,574.60
77,125.20
-
-
289,944.30
Issuance/Reduction of Debt, Net
12,547.00
6,012.70
290,140.00
14,000.00
114,000.00
Net Financing Cash Flow
4,027.60
98,092.80
304,054.30
14,000.00
175,944.30
Net Change in Cash
284,068.90
266,210.00
105,827.90
4,914.70
51,053.20
Free Cash Flow
191,312.20
375,515.30
298,407.60
18,033.60
124,790.60
Deferred Taxes & Investment Tax Credit
9,223.40
8,110.90
12,210.70
17,943.90
898.60
4,713.30
Other Uses
86,823.40
-
100,377.40
-
-

About HPGC Renmintongtai Pharmaceutical

View Profile
Address
418 Hayao Road
Harbin Heilongjiang 150071
China
Employees -
Website http://www.hyrmtt.com.cn
Updated 07/08/2019
HPGC Renmintongtai Pharmaceutical Corp. engages in the wholesale and retail of pharmaceutical products. It operates through the following business segments: Drug retail, Commercial wholesale, Logistics, E-commerce, Specialist hospital, and Chinese medicine. The Drug retail segment includes chain drugstores and network distribution of pharmaceutical products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.